Imodium and Uloric drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Uloric (febuxostat). Common drug interactions include orthostatic hypotension among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Uloric. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.



On Jul, 21, 2026

83 people who take Imodium and Uloric together, and have interactions are studied.

Imodium and Uloric drug interactions.

What are the common drug interactions of Imodium and Uloric, by gender? *:

female:

  1. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  2. Renal cyst (kidney cyst)
  3. Vitamin d deficiency
  4. Balance disorder
  5. Bladder disorder
  6. Bone disorder
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Oedema peripheral (superficial swelling)
  10. Pain

male:

  1. Cough
  2. Rash
  3. Pyrexia (fever)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Urinary tract infection
  6. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Imodium and Uloric, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Death
  3. Device related infection
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Haematoma (collection of blood outside the blood vessels)
  7. Local swelling (swelling at the site of some application of substance or injury)
  8. Oesophageal adenocarcinoma metastatic (a cancer tumour of an epithelium in oesophagus spreads to other parts)
  9. Pain
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Infusion site swelling
  3. Joint injury
  4. Kidney infection
  5. Renal cyst (kidney cyst)
  6. Sinusitis (inflammation of sinus)
  7. Urinary tract infection
  8. Bladder disorder
  9. Asthma
  10. Balance disorder

60+:

  1. Chronic kidney disease
  2. Pancreatitis (inflammation of pancreas)
  3. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  4. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  5. Muscle atrophy (a decrease in the mass of the muscle)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  8. Vitamin d deficiency
  9. Cough
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. High Blood Pressure: 14 people, 16.87%
  2. Immunodeficiency Common Variable: 9 people, 10.84%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 10.84%
  4. Multiple Myeloma (cancer of the plasma cells): 8 people, 9.64%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 9.64%
  6. Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 8.43%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 8.43%
  8. Pain: 6 people, 7.23%
  9. Stress And Anxiety: 5 people, 6.02%
  10. High Blood Cholesterol: 5 people, 6.02%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Uloric?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Uloric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uloric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uloric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and febuxostat (the active ingredients of Imodium and Uloric, respectively), and Imodium and Uloric (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: